Calendrier des promotions Halozyme Therapeutics, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise
Halozyme Therapeutics, Inc. работает как компания, занимающаяся биофармацевтической технологической платформой в США, Швейцарии и на международном уровне. Продукция компании основана на технологии доставки лекарств ENHANZE, запатентованном рекомбинантном ферменте гиалуронидазы человека (rHuPH20), который обеспечивает подкожную доставку инъекционных биопрепаратов, таких как моноклональные антитела и другие терапевтические молекулы, а также небольших молекул и жидкостей. plus de détailsIPO date | 2004-03-16 |
---|---|
ISIN | US40637H1095 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.halozyme.com |
Цена ао | 52.8 |
Changement de prix par jour: | 0% (52.8) |
---|---|
Changement de prix par semaine: | +4.53% (50.51) |
Changement de prix par mois: | +10.39% (47.83) |
Changement de prix sur 3 mois: | -2.13% (53.95) |
Changement de prix sur six mois: | -3.56% (54.75) |
Changement de prix par an: | +53.35% (34.43) |
Evolution du prix sur 3 ans: | +48.82% (35.48) |
Evolution du prix sur 5 ans: | +185.25% (18.51) |
Evolution des prix sur 10 ans: | +264.14% (14.5) |
Evolution des prix depuis le début de l'année: | +11.06% (47.54) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
---|---|---|---|---|---|---|---|---|---|
09.10.2024 | 09.10.2024 | HELEN TORLEY Officer |
Achat | 52.58 | 525 800 | 10000 | 0 | 0.01 | lien |
08.10.2024 | 08.10.2024 | HELEN TORLEY Officer |
Achat | 54 | 540 000 | 10000 | 0 | 0.01 | lien |
26.09.2024 | 26.09.2024 | HELEN TORLEY Officer |
Achat | 56.1 | 561 000 | 10000 | 0 | 0.01 | lien |
25.09.2024 | 25.09.2024 | HELEN TORLEY Officer |
Achat | 56.34 | 563 400 | 10000 | 0 | 0.01 | lien |
24.09.2024 | 24.09.2024 | HELEN TORLEY Officer |
Achat | 58.21 | 582 100 | 10000 | 0 | 0.01 | lien |
11.09.2024 | 11.09.2024 | HELEN TORLEY Officer |
Achat | 59.09 | 590 900 | 10000 | 0 | 0.01 | lien |
10.09.2024 | 10.09.2024 | HELEN TORLEY Officer |
Achat | 59.09 | 590 900 | 10000 | 0 | 0.01 | lien |
27.08.2024 | 27.08.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Achat | 18.41 | 102 728 | 5580 | 0 | 0 | lien |
20.08.2024 | 20.08.2024 | MICHAEL LABARRE Officer |
Achat | 61.06 | 610 600 | 10000 | 0 | 0.01 | lien |
28.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Vente | 52.04 | 520 400 | 10000 | 0 | -0.01 | lien |
28.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Achat | 22.5 | 225 000 | 10000 | 0 | 0.01 | lien |
27.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Vente | 51.93 | 519 300 | 10000 | 0 | -0.01 | lien |
27.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Achat | 22.5 | 225 000 | 10000 | 0 | 0.01 | lien |
26.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Vente | 51.82 | 518 200 | 10000 | 0 | -0.01 | lien |
26.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Achat | 22.5 | 225 000 | 10000 | 0 | 0.01 | lien |
17.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Vente | 38.49 | 384 900 | 10000 | 0 | -0.01 | lien |
17.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Achat | 8.11 | 81 100 | 10000 | 0 | 0.01 | lien |
16.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Vente | 38.35 | 383 500 | 10000 | 0 | -0.01 | lien |
16.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Achat | 8.11 | 81 100 | 10000 | 0 | 0.01 | lien |
03.01.2023 | 04.01.2023 | Snyder Mark Howard SVP, GENERAL COUNSEL |
Achat | 53.98 | 410 842 | 7611 | 0 | 0.01 | lien |
13.12.2022 | 13.12.2022 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Vente | 58.67 | 586 700 | 10000 | 0 | -0.01 | lien |
15.02.2022 | 17.02.2022 | Torley Helen President and CEO |
Achat | 33.1 | 433 345 | 13092 | 0 | 0.01 | lien |
15.02.2022 | 17.02.2022 | LaBrosse Nicole SVP, Chief Financial Officer |
Achat | 33.1 | 41 541 | 1255 | 0 | 0 | lien |
15.02.2022 | 17.02.2022 | LaBarre Michael J. SVP, Chief Technical Officer |
Achat | 33.1 | 112 077 | 3386 | 0 | 0 | lien |
12.10.2021 | 12.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Achat | 13.1 | 105 455 | 8050 | 0 | 0.01 | lien |
04.10.2021 | 04.10.2021 | Torley Helen President and CEO |
Vente | 40.09 | 2 004 500 | 50000 | 0 | -0.04 | lien |
04.10.2021 | 04.10.2021 | Torley Helen President and CEO |
Achat | 14.66 | 733 000 | 50000 | 0 | 0.04 | lien |
01.10.2021 | 01.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Vente | 39.93 | 1 175 940 | 29450 | 0 | -0.02 | lien |
01.10.2021 | 01.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Achat | 13.1 | 385 795 | 29450 | 0 | 0.02 | lien |
10.08.2021 | 10.08.2021 | Torley Helen President and CEO |
Vente | 41.11 | 2 055 500 | 50000 | 0 | -0.04 | lien |
10.08.2021 | 10.08.2021 | Torley Helen President and CEO |
Achat | 14.66 | 733 000 | 50000 | 0 | 0.04 | lien |
15.07.2021 | 15.07.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Achat | 6.55 | 96 187 | 14685 | 0 | 0.01 | lien |
01.02.2021 | 01.02.2021 | Torley Helen President and CEO |
Vente | 47.84 | 2 392 000 | 50000 | 0 | -0.03 | lien |
01.02.2021 | 01.02.2021 | Torley Helen President and CEO |
Achat | 14.66 | 733 000 | 50000 | 0 | 0.03 | lien |
01.02.2021 | 01.02.2021 | Kelley Kenneth J Director |
Vente | 48.12 | 240 600 | 5000 | 0 | 0 | lien |
21.12.2020 | 21.12.2020 | LaBarre Michael J. SVP, Chief Technical Officer |
Vente | 42.58 | 510 960 | 12000 | 0 | -0.01 | lien |
Établissements | Volume | Partager, % |
---|---|---|
Blackrock Inc. | 18630963 | 14.66 |
Vanguard Group Inc | 13259514 | 10.44 |
Artisan Partners Limited Partnership | 6689058 | 5.26 |
State Street Corporation | 6475549 | 5.1 |
Snyder Capital Management, LP | 3709599 | 2.92 |
AllianceBernstein L.P. | 3463694 | 2.73 |
Macquarie Group Limited | 3282640 | 2.58 |
JP Morgan Chase & Company | 3093932 | 2.44 |
Geode Capital Management, LLC | 2919763 | 2.3 |
GW&K Investment Management, LLC | 2226538 | 1.75 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Ms. Amy Marinne Fox | Chief Human Resources Officer | N/A | |
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. | President, CEO & Director | 1.82M | 1963 (62 année) |
Ms. Nicole LaBrosse | Senior VP & CFO | 849.36k | 1983 (42 année) |
Mr. Mark Snyder Esq. | Senior VP & Chief Legal Officer | 912.87k | |
Ms. Tram Bui | Head of Investor Relations & Corporate Communications | N/A | |
Dr. Michael J. LaBarre Ph.D. | Senior VP & CTO | 843.89k | 1964 (61 année) |
Ms. Cortney Caudill M.B.A. | Chief Operations Officer | N/A | |
Mr. Gary Grote | Chief Commercial Officer | ||
Dr. Christopher Wahl M.B.A., M.D. | Chief Business Officer |
Adresse: United States, San Diego, CA , 11388 Sorrento Valley Road - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://www.halozyme.com
Site web: http://www.halozyme.com